Table 4 Logistic regression model for CR-POPF occurrence in 233 unmatched patients
Variable | Univariate | Multivariate | |||
|---|---|---|---|---|---|
With CR-POPF, n (%) | Without CR-POPF, n (%) | P value | Relative risk (95% CI) | P value | |
PE approach | < 0.001 | 0.009 | |||
End-to-side | 17 (15.6) | 92 (84.4) | 1 | ||
Duct-to-mucosa | 1 (0.8) | 123 (99.2) | 0.11 (0.02–0.57) | ||
BMI (kg/m2) | < 0.001 | < 0.001 | |||
< 24 | 5 (3.0) | 161 (97.0) | Ref. | – | |
24–28 | 6 (10.9) | 49 (89.1) | 11.89 (2.14–65.94) | 0.005 | |
> 28 | 7 (58.3) | 5 (41.7) | 49.39 (5.20–469.19) | < 0.001 | |
Diabetes | < 0.001 | 0.001 | |||
No | 6 (3.2) | 181 (96.8) | 1 | ||
Yes | 12 (26.1) | 34 (73.9) | 10.54 (2.55–43.61) | ||
Final diagnosis | 0.016 | 0.324 | |||
Pancreatic cancer | 6 (4.3) | 134 (95.7) | 1 | ||
Other pathologic findings | 12 (12.9) | 81 (87.1) | 2.24 (0.45–11.10) | ||
Pancreas texture | 0.018 | 0.480 | |||
Firm | 8 (5.0) | 153 (95.0) | 1 | ||
Soft | 10 (13.9) | 62 (86.1) | 1.81 (0.35–9.45) | ||
Pancreatic duct diameter | 0.029 | 0.021 | |||
≧ 3 mm | 10 (5.4) | 174 (94.6) | 1 | ||
< 3 mm | 8 (16.3) | 41 (83.7) | 6.72 (1.33–33.88) | ||
Neoplastic | 0.175 | 0.865 | |||
No | 2 (20.0) | 8 (80.0) | 1 | ||
Yes | 16 (7.2) | 207 (92.8) | 0.73 (0.02–26.69) | ||